Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer 2024-12-30 13:28
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging 2024-12-30 06:00
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference 2024-12-27 09:44
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved 2024-12-26 17:09
Kickstart 2025 with Expert Holiday Health Tips 2024-12-23 15:21
SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore 2024-12-23 09:00
Macrogen Consortium win tender for National Bio Big Data Project 2024-12-23 08:00
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration 2024-12-20 20:20
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete 2024-12-19 17:02
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection 2024-12-19 01:00
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model 2024-12-18 21:43
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial) 2024-12-18 19:34
Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award" 2024-12-18 11:43
Neurizon Files IND Application to Support HEALEY ALS Platform Trial 2024-12-18 10:59
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients 2024-12-18 08:00
Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024 2024-12-17 20:40
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis 2024-12-17 11:48
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg 2024-12-16 22:08
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea 2024-12-16 10:30
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China 2024-12-16 07:55
1 2 3 4 5 253